The Geisel School of Medicine has launched a $250 million fundraising campaign as part of Dartmouth’s institution-wide campaign. Interaction: The Campaign for Dartmouth Medicine will amplify the medical school’s academic vitality and global impact, elevating Geisel’s stature as a community of scholars and learners with an outsized influence in forging new solutions and leading improvements in healthcare.
Dartmouth study finds e-cigarette use could do more harm than good by substantially increasing the number of adolescents and young adults who eventually become cigarette smokers and marginally decreasing the number of adult cigarette smokers who quit.
Noted molecular biologist James Bliska, PhD, is joining the Geisel School of Medicine at Dartmouth as a Distinguished Professor in Microbiology and Immunology and senior lead faculty member of the Personalized Treatments for Cystic Fibrosis (CF) Cluster, a cross-Dartmouth group of investigators established to develop innovative, personalized medicine and treatments for CF and lung infections caused by opportunistic pathogens.
Sandra L. Wong, MD, MS, chair of surgery at the Geisel School of Medicine and Dartmouth-Hitchcock, has been named the William N. and Bessie Allyn Professor in Surgery.
A Dartmouth-led study found that social media big data can be used to understand communication and behavioral patterns related to prescription drug abuse.
Geisel School of Medicine Dean Duane Compton, PhD, announced today that Gregory Ogrinc, MD, MS, an internationally recognized innovator in medical education, has been name the Senior Associate Dean for Medical Education, a role that he has served in on an interim basis since 2014.
Dartmouth’s Graduate Program in Quantitative Biomedical Sciences (QBS) is offering a new master’s degree with a concentration in health data science beginning in fall 2018.
A team of Geisel researchers will receive funding from the Patient-Centered Outcomes Research Institute (PCORI) to design new methods for comparing the effectiveness of alternative therapies that can lead to improvements in practice and better outcomes for patients.
Geisel researchers take a close look at New Hampshire’s complex opioid epidemic, and one city’s novel response.
Dartmouth-led research is in early phase drug discovery and finds promising therapeutic leads after targeting vulnerabilities in nervous system tumors, including glioblastoma.